AstraZeneca, Peregrine Pharmaceuticals to Collaborate on Immuno-Oncology Combination Clinical Trial
August 24, 2015 at 04:27 AM EDT
AstraZeneca (NYSE: AZN) and Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today announced that they have entered into a cancer ...